{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T21:54:24Z","timestamp":1775512464635,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There are less studies focusing on the sedative therapy of acute myocardial infarction (AMI) critical patients. This study aim to compare the impact on the prognosis of AMI critical patients of using midazolam, propofol and dexmedetomidine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We collected clinical data from the Medical Information Mart for Intensive Care III (MIMIC III) database. Data on 427 AMI patients with sedatives using were recruited from in Coronary Heart Disease Intensive Care unit (CCU).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 143 patients in midazolam using, 272 in propofol using and 28 in dexmedetomidine using. The rate of 28-days mortality was 23.9% in overall patients. Through logistic regression analysis, only midazolam using was significant association with increased 28-days mortality when compared with propofol or dexmedetomidine using. In the subgroup analysis of age, gender, body mass index (BMI), white blood cell (WBC), beta-block, and revascularization, the association between midazolam using and increased 28-days mortality remained significantly. Through propensity score matching, 140 patients using midazolam and 192 using non-midazolam were successfully matched, the midazolam using presented with higher rate of CCU mortality, hospital mortality and 28-days mortality, longer of mechanical ventilation time and CCU duration. E-value analysis suggested robustness to unmeasured confounding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Propofol or dexmedetomidine are preferred to be used in AMI critical patients for sedative therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-021-02385-9","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T06:02:33Z","timestamp":1638856953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Comparing the impact on the prognosis of acute myocardial infarction critical patients of using midazolam, propofol, and dexmedetomidine for sedation"],"prefix":"10.1186","volume":"21","author":[{"given":"Xiaowei","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"issue":"6","key":"2385_CR1","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s001340050917","volume":"25","author":"M Sydow","year":"1999","unstructured":"Sydow M, Neumann P. Sedation for the critically ill. Intensive Care Med. 1999;25(6):634\u20136.","journal-title":"Intensive Care Med"},{"issue":"3","key":"2385_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/0023677217724485","volume":"52","author":"EN Ter Horst","year":"2018","unstructured":"Ter Horst EN, Krijnen P, Flecknell P, Meyer KW, Kramer K, van der Laan AM, Piek JJ, Niessen H. Sufentanil-medetomidine anaesthesia compared with fentanyl\/fluanisone-midazolam is associated with fewer ventricular arrhythmias and death during experimental myocardial infarction in rats and limits infarct size following reperfusion. Lab Anim. 2018;52(3):271\u20139.","journal-title":"Lab Anim"},{"issue":"12","key":"2385_CR3","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.resuscitation.2010.07.021","volume":"81","author":"S Mimuro","year":"2010","unstructured":"Mimuro S, Katoh T, Suzuki A, Yu S, Adachi YU, Uraoka M, Sano H, Sato S. Deterioration of myocardial injury due to dexmedetomidine administration after myocardial ischaemia. Resuscitation. 2010;81(12):1714\u20137.","journal-title":"Resuscitation"},{"issue":"14","key":"2385_CR4","first-page":"6339","volume":"23","author":"WY Zhang","year":"2019","unstructured":"Zhang WY, Zhang QL, Xu MJ. Effects of propofol on myocardial ischemia reperfusion injury through inhibiting the JAK\/STAT pathway. Eur Rev Med Pharmacol Sci. 2019;23(14):6339\u201345.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2385_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jss.2018.03.040","volume":"228","author":"YF Chang","year":"2018","unstructured":"Chang YF, Chao A, Shih PY, Hsu YC, Lee CT, Tien YW, Yeh YC, Chen LW. Comparison of dexmedetomidine versus propofol on hemodynamics in surgical critically ill patients. J Surg Res. 2018;228:194\u2013200.","journal-title":"J Surg Res"},{"key":"2385_CR6","doi-asserted-by":"publisher","first-page":"160035","DOI":"10.1038\/sdata.2016.35","volume":"3","author":"AE Johnson","year":"2016","unstructured":"Johnson AE, Pollard TJ, Shen L, Lehman LW, Feng M, Ghassemi M, Moody B, Szolovits P, Celi LA, Mark RG. MIMIC-III, a freely accessible critical care database. SCI DATA. 2016;3:160035.","journal-title":"SCI DATA"},{"issue":"6","key":"2385_CR7","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/jama.2018.21554","volume":"321","author":"S Haneuse","year":"2019","unstructured":"Haneuse S, VanderWeele TJ, Arterburn D. Using the E-value to assess the potential effect of unmeasured confounding in observational studies. JAMA. 2019;321(6):602\u20133.","journal-title":"JAMA"},{"issue":"3","key":"2385_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s12350-016-0453-z","volume":"23","author":"T Rasmussen","year":"2016","unstructured":"Rasmussen T, Follin B, Kastrup J, Christensen TE, Hammelev KP, Kjaer A, Hasbak P. Myocardial perfusion of infarcted and normal myocardium in propofol-anesthetized minipigs using (82)Rubidium PET. J Nucl Cardiol. 2016;23(3):599\u2013603.","journal-title":"J Nucl Cardiol"},{"issue":"10245","key":"2385_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0140-6736(20)30631-0","volume":"396","author":"A Turan","year":"2020","unstructured":"Turan A, Duncan A, Leung S, Karimi N, Fang J, Mao G, Hargrave J, Gillinov M, Trombetta C, Ayad S, et al. Dexmedetomidine for reduction of atrial fibrillation and delirium after cardiac surgery (DECADE): a randomised placebo-controlled trial. Lancet. 2020;396(10245):177\u201385.","journal-title":"Lancet"},{"issue":"9","key":"2385_CR10","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1592\/phco.24.13.1177.38089","volume":"24","author":"CE Mancuso","year":"2004","unstructured":"Mancuso CE, Tanzi MG, Gabay M. Paradoxical reactions to benzodiazepines: literature review and treatment options. Pharmacotherapy. 2004;24(9):1177\u201385.","journal-title":"Pharmacotherapy"},{"issue":"6","key":"2385_CR11","first-page":"558","volume":"43","author":"AH Ates","year":"2015","unstructured":"Ates AH, Kul S. Acute coronary syndrome due to midazolam use: Kounis syndrome during a transurethral prostatectomy. Turk Kardiyol Dern Ars. 2015;43(6):558\u201361.","journal-title":"Turk Kardiyol Dern Ars"},{"issue":"5","key":"2385_CR12","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.athoracsur.2015.06.030","volume":"100","author":"X Liu","year":"2015","unstructured":"Liu X, Hong H, Zhang H, Xu Z, Liu J, Qiu L. Treatment strategies for primary tumors of the heart in children: a 10-year experience. Ann Thorac Surg. 2015;100(5):1744\u20139.","journal-title":"Ann Thorac Surg"},{"issue":"11","key":"2385_CR13","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.2012.304","volume":"307","author":"SM Jakob","year":"2012","unstructured":"Jakob SM, Ruokonen E, Grounds RM, Sarapohja T, Garratt C, Pocock SJ, Bratty JR, Takala J. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA. 2012;307(11):1151\u201360.","journal-title":"JAMA"},{"issue":"2","key":"2385_CR14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s00134-008-1296-0","volume":"35","author":"E Ruokonen","year":"2009","unstructured":"Ruokonen E, Parviainen I, Jakob SM, Nunes S, Kaukonen M, Shepherd ST, Sarapohja T, Bratty JR, Takala J. Dexmedetomidine versus propofol\/midazolam for long-term sedation during mechanical ventilation. Intensive Care Med. 2009;35(2):282\u201390.","journal-title":"Intensive Care Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02385-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-021-02385-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02385-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T06:10:50Z","timestamp":1638857450000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-021-02385-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2385"],"URL":"https:\/\/doi.org\/10.1186\/s12872-021-02385-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-748206\/v1","asserted-by":"object"}]},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"24 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the principals of the Declaration of Helsinki. MIMIC III database used in the present study is publicly available database and was approved by the Institutional Review Boards (IRB) of the Massachusetts Institute of Technology (Cambridge, MA). All protected health information were fully anonymized for researcher, and a waiver of the requirement for informed consent was included in the IRB approval of Massachusetts Institute of Technology (Cambridge, MA). Therefore, the ethical approval statement and the need for informed consent were waived for this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"584"}}